IDEAS home Printed from https://ideas.repec.org/a/adp/jgjpps/v6y2018i5p102-104.html
   My bibliography  Save this article

Review of Pembrolizumab and other Anti PD-1/PD-L1 Antibodies

Author

Listed:
  • Caleb P Gottlich MS

    (Orthopedic Surgery Department, Johns Hopkins School of Medicine, USA)

Abstract

Immunotherapies are rapidly becoming favored amongst physicians for the treatment of various oncologic process due to their more favorable adverse reaction profile in addition to their increased ability to target specific cancer tissue as opposed to the usual widespread devastation of healthy tissue that can accompany chemotherapy and radiation therapy. One class of immunotherapies that has shown exquisite promise in terms of efficacy and limited immune related adverse events is the anti-PD-1/PD-L1 antibodies, which falls under the immunotherapy classification of check point inhibitor. In this paper, we will give a brief review of the background, mechanism, and side effects common to PD-L1/PD-1 inhibitors as a cancer therapy.

Suggested Citation

  • Caleb P Gottlich MS, 2018. "Review of Pembrolizumab and other Anti PD-1/PD-L1 Antibodies," Global Journal of Pharmacy & Pharmaceutical Sciences, Juniper Publishers Inc., vol. 6(5), pages 102-104, December.
    • Handle: RePEc:adp:jgjpps:v:6:y:2018:i:5:p:102-104
    DOI: 10.19080/GJPPS.2018.06.555696
    as

    Download full text from publisher

    File URL: https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555696.pdf
    Download Restriction: no
    File URL: https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555696.php
    Download Restriction: no
    File URL: https://libkey.io/10.19080/GJPPS.2018.06.555696?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:jgjpps:v:6:y:2018:i:5:p:102-104. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.